Wockhardt: Zaynich Launch Unlocks a Multi-Market Anti-Infective Franchise
US and India approvals in May 2026 turn a two-decade antibiotic programme into a commercial platform. Insulin pens, Emrok and UK-Ireland cash flow...
98 Views
Wockhardt: Beyond Zaynich,the Franchise Is Just Getting Started
FDA approved Zaynich, India's first NCE, with WCK 6777 on the horizon as the next potential blockbuster. Wockhardt sees genuine PAT turnaround and...
105 Views
Zaynich Approvals: How Wockhardt Could Unlock a $7 Billion Opportunity
Wockhardt's Zaynich, targeting superbugs, gets US FDA approval, opening up potential multi-billion dollar markets. The real challenge now lies in...
147 Views
#161 India Insights: India Eyes Rare Earth Push; IndusInd's Prerequisites from RBI, Insulin Scale Up
India aims to localize rare earth magnet production for EV and tech sectors, Hinduja Group faces RBI conditions for Indusind Bank
596 Views
#160 India Insight: Adani Energy ₹6K Cr+ Inv, Tata Apple Repair, Maruti Suzuki Solar Boost
Adani Energy Solutions invests INR 6,000 crore in centralised cooling, Apple appoints Tata for repairs in India, Maruti Suzuki expands solar...
563 Views